Weighing Cost Vs. Cure in Hepatitis C Treatments

Raulo Frear, PharmD, general manager of OmedaRx, discusses the high initial cost of hepatitis C drugs like Sovaldi compared with the long term cost of treating the disease.

Raulo Frear, PharmD, general manager of OmedaRx, discusses the high initial cost of hepatitis C drugs like Sovaldi compared with the long term cost of treating the disease.

Related Content:

InterviewsHepatitisHIVSpecialty Pharmacy
FDA Grants Orphan Drug Designation to Alrizomadlin for Stage IIB-IV Melanoma
FDA Approves Pembrolizumab, Lenvatinib Combination Therapy for Advanced Endometrial Carcinoma
FDA Grants Breakthrough Therapy Designation to Venetoclax for Higher Risk Myelodysplastic Syndromes